White Oak Capital - Pharma and Healthcare Fund · Direct · Growth
NAV
₹15.8130
as of 17 Jun 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +16.43%
- 3Y
- —
- 5Y
- —
- Since Inception
- +20.87%
SIP returns (XIRR)
- 1Y
- +20.94%
- 3Y
- —
- 5Y
- —
- Since Inception
- +19.01%
Returns calculated from 16 January 2024 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Performance Comparison
Thinking about White Oak Capital - Pharma and Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Investment Objective
White Oak Capital - Pharma and Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
White Oak Capital - Pharma and Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by WhiteOak Capital Mutual Fund. The fund has been operational for over 2 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations